Recovery of ζ-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer

British Journal of Cancer

Volumn 86, Issue 2, 2002, Pages 168-178

  Meidenbauer, N ^a   Gooding, W ^a   Spitler, L ^c   Harris, D ^d   Whiteside, T L ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Jenner Biotherapies   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Immune monitoring; Prostate cancer; PSA; T cell functions; Vaccination

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 10; INTRALIPID; JBT 1001; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT ANTIGEN; VACCINE;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; T LYMPHOCYTE; TREATMENT OUTCOME; VACCINATION;

AGED; CANCER VACCINES; CARCINOMA; DISEASE-FREE SURVIVAL; FLOW CYTOMETRY; GLOBINS; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 0037148442     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600039     Document Type: Article

References (32)

1. Preparation and use of liposomes in immunological studies
2. Evaluation of the modified ELISPOT assay for interferon-γ production in monitoring of cancer patients receiving anti-tumour vaccines
3. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: Clinical relevance and effects of cytokine therapy
4. T-cell receptor zeta-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma
5. A lack of evidence for down-modulation of CD3 zeta expression in colorectal carcinoma and pregnancy using multiple detection methods
6. Serum interleukin-10 is an independent prognostic factor in advanced solid tumors
7. Decreased ζ-chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma
8. Caspase-mediated degradation of T-cell receptor zeta-chain
9. Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy
10. Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer
11. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells
12. Hydrogen peroxide secreted by tumor-derived macrophages down modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediatd cytotoxicity
13. Expression of signal transducing T-cell receptor zeta molecules after adoptive immunotherapy in patients with gastric and colon cancer
14. Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer
15. + T-cell frequencies by the ELISPOT assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide
16. Dendritic cell-based immunotherapy of prostate cancer: Immune monitoring of a phase II clinical trial
17. Molecular cloning of human prostate specific antigen cDNA
18. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions
19. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease
20. Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer
21. Interleukin-10
22. Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients
23. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy
24. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells: Implications for altered expression of T cell receptor in tumor-associated lymphocytes
25. Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma
26. Signal transduction abnormalities, apoptosis and reduced proliferation of lymphocytes in the peripheral blood and at the tumor site of patients with oral carcinoma
27. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients
28. Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL)derived from renal-cell carcinoma: Relationship with TIL phenotype and function
29. Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients
30. Liposomes as carriers for vaccines
31. Signaling defects in T lymphocytes of patients with malignancy
32. Alterations in T cell receptor and signal transduction molecules in melanoma patients